Specialty Pharmacy

The report examines changing areas that will impact pharmacists.

Pharmacy teams from 6 institutes won the ASHP Best Practices Award.

Newly developed technology maps HIV inserts across the human genome.

Distinct subsets of synovial fibroblasts in rheumatoid arthritis development identified.

Top news of the week on Specialty Pharmacy Times.

Medical marijuana may fall under specialty pharmacy in the future.

The new method makes breast imaging less risky, and can lessen false-positive readings.

Around 14 million people have HIV worldwide – yet an estimated 40% don’t know they’re infected.

Study captures major changes in infectious diseases between 1980 through 2014.

A newly developed hand-held breath analyzer tests for elevated levels of acetone, which is strongly associated with undiagnosed diabetes.

Trametinib targets a type of immune cell that inhibits T cell response in cancer.

Top news of the day from across the health care landscape.

A first-of-its-kind study successfully transferred an ovary from one individual to another.

Rheumatic and myocardial inflammation can be treated with disease modifying anti-rheumatic drugs.

ASHP’s 2016 Midyear Clinical Meeting is the largest gathering of clinical pharmacists in the world.

New progress made towards the development of an HIV vaccine.

Variants of GAL are more common among women, which may explain the high prevalence of multiple sclerosis.

A novel drug used in combination with radiation found to be a more effective treatment for prostate cancer.

About 1 in 6 women diagnosed with breast cancer have a symptom other than a lump.

The rubella virus stays in the body of patients with severe deficiencies in their immune defenses, making them more susceptible to side effects.

Top news of the day from across the health care landscape.

Rapid reduction of rheumatoid arthritis symptoms rated as the most important factor in choosing a treatment.

Broadly neutralizing antibodies (bNAbs) may hold the key to eliminating HIV-1.

Patients with multiple comorbidities contribute to escalating health care spending.

Launch of South Africa-based clinical trial provides hope for the defeat of HIV.

Patients with early stage rheumatoid arthritis may benefit from tapering DMARD therapy.

Study precisely maps the location of disease causing mutations.

Determining the contents of extracellular vesicles may create targeted treatments.